Skip to content Skip to footer

How Does SIGMAR1 Recombinant Protein Help Study Alzheimer’s Disease?

Neurons are specialized nerve cells in the brain and nervous system that continuously communicate. At the same time, our brain produces and clears proteins, mitochondria generate energy, and the endoplasmic reticulum (ER) maintains protein and calcium balance. These processes work together to keep neurons healthy and functioning properly.  However, when this cellular balance is disrupted,…

Read more

Viz.ai Partners with Cortechs.ai to Expand AI Platform into Neurodegenerative Disease Care

Shots: Viz.ai has partnered with Cortechs.ai to integrate its NeuroQuant & NeuroQuant MS into its AI-powered care coordination platform, expanding into neurodegenerative diseases The collaboration will initially focus on multiple sclerosis by integrating Cortechs.ai’s quantitative MRI analysis into Viz.ai’s clinical workflow & care coordination platform to improve MS identification, characterization, & management The company plans…

Read more

Viewpoints_Stella Sarraf

Enhancing Neurodegenerative Care: Stella Sarraf from Spinogenix in an Enlightening Dialogue Exchange with PharmaShots

Shots:  With a broad portfolio of candidates in ALS, Alzheimer’s disease, Schizophrenia, and Fragile X Syndrome, Spinogenix initiated the P-II study evaluating SPG302 for the treatment of patients with Alzheimer’s disease  SPG302, a synaptic regenerative therapy, is aimed to provide an effective and patient-friendly solution as a daily pill for ALS and Alzheimer’s disease  Today…

Read more